# Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial

> **NCT04652908** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of California, Davis** · enrollment: 55 (estimated)

## Conditions studied

- Myelomeningocele

## Interventions

- **BIOLOGICAL:** Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix
- **OTHER:** Untreated contemporaneous cohort

## Key facts

- **NCT ID:** NCT04652908
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-21
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04652908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04652908, "Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04652908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*